- Details
- Description
Packaging Size:
21 capsules
Strength:
125 mg
Composition:
Palbociclib
Treatment:
Anti-Cancer / Oncology
Form:
Capsule
Brand:
Palbokin 125
Manufacturer:
Ziska Pharmaceuticals Limited
Palbokin 125 (Palbociclib) is an oral targeted anti-cancer medicine containing palbociclib, a cyclin-dependent kinase (CDK) 4/6 inhibitor that helps slow the growth and division of cancer cells. It is primarily used in combination with hormonal therapy for the treatment of hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer. Palbokin 125 contains 125 mg of palbociclib and is supplied in a 21-capsule pack.
